In the pursuit of market outperformance, investors navigate the landscape of stock selection. The right picks can play a pivotal role in enhancing your wealth.
The price of Cogent Biosciences Inc (NASDAQ: COGT) closed at $7.29 in the last session, down -3.95% from day before closing price of $7.59. In other words, the price has decreased by -$3.95 from its previous closing price. On the day, 1.23 million shares were traded. COGT stock price reached its highest trading level at $7.87 during the session, while it also had its lowest trading level at $7.2.
Ratios:
We take a closer look at COGT’s different ratios to gain a better understanding of the stock. For the most recent quarter (mrq), Quick Ratio is recorded 5.32 and its Current Ratio is at 5.32. In the meantime, Its Debt-to-Equity ratio is 0.07 whereas as Long-Term Debt/Eq ratio is at 0.06.
Upgrades & Downgrades
In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for this company, Scotiabank on March 07, 2025, initiated with a Sector Outperform rating and assigned the stock a target price of $17.
Robert W. Baird Downgraded its Outperform to Neutral on February 26, 2024, whereas the target price for the stock was revised from $14 to $8.
Insider Transactions:
An investor can also benefit from insider trades by learning what management is thinking about the future direction of stock prices. A recent insider transaction in this stock occurred on Jan 14 ’25 when Pinnow Cole bought 43,750 shares for $7.60 per share. The transaction valued at 332,412 led to the insider holds 45,848 shares of the business.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, COGT now has a Market Capitalization of 829966464 and an Enterprise Value of 646819776.
Stock Price History:
The Beta on a monthly basis for COGT is 1.56, which has changed by 0.034042597 over the last 52 weeks, in comparison to a change of 0.07903516 over the same period for the S&P500. Over the past 52 weeks, COGT has reached a high of $12.61, while it has fallen to a 52-week low of $5.73. The 50-Day Moving Average of the stock is -9.43%, while the 200-Day Moving Average is calculated to be -21.23%.
Shares Statistics:
According to the various share statistics, COGT traded on average about 1.39M shares per day over the past 3-months and 1163510 shares per day over the past 10 days. A total of 110.46M shares are outstanding, with a floating share count of 95.39M. Insiders hold about 16.22% of the company’s shares, while institutions hold 91.79% stake in the company. Shares short for COGT as of 1740700800 were 11661402 with a Short Ratio of 8.36, compared to 1738281600 on 10126418. Therefore, it implies a Short% of Shares Outstanding of 11661402 and a Short% of Float of 11.3000005.
Dividends & Splits
Against a Trailing Annual Dividend Yield of 0.0
Earnings Estimates
The stock of Cogent Biosciences Inc (COGT) is currently being evaluated by 7.0 analysts who are actively contributing to its market rating.The consensus estimate for the next quarter is -$0.56, with high estimates of -$0.39 and low estimates of -$0.66.
Analysts are recommending an EPS of between -$1.58 and -$2.65 for the fiscal current year, implying an average EPS of -$2.18. EPS for the following year is -$1.77, with 7.0 analysts recommending between -$1.32 and -$2.58.
